5L6P
EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)
Summary for 5L6P
Entry DOI | 10.2210/pdb5l6p/pdb |
Descriptor | Ephrin type-B receptor 3, ~{N}-(4-phenylazanylquinazolin-7-yl)ethanamide, 1,4-DIETHYLENE DIOXIDE, ... (4 entities in total) |
Functional Keywords | kinase, irreversible inhibitor, quinazoline, signaling, transferase |
Biological source | Homo sapiens (Human) |
Cellular location | Cell membrane ; Single-pass type I membrane protein : P54753 |
Total number of polymer chains | 1 |
Total formula weight | 34132.13 |
Authors | Schimpl, M.,Overman, R.,Kung, A.,Chen, Y.-C.,Ni, F.,Zhu, J.,Turner, M.,Molina, H.,Zhang, C. (deposition date: 2016-05-30, release date: 2016-08-10, Last modification date: 2024-01-10) |
Primary citation | Kung, A.,Chen, Y.C.,Schimpl, M.,Ni, F.,Zhu, J.,Turner, M.,Molina, H.,Overman, R.,Zhang, C. Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3. J.Am.Chem.Soc., 138:10554-10560, 2016 Cited by PubMed: 27478969DOI: 10.1021/jacs.6b05483 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.26 Å) |
Structure validation
Download full validation report